Fundraising Fox

G1 Therapeutics

Research Triangle Park, US · Delaware corporation · 5 known investors

g1therapeutics.com ↗

G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

Biotech

Founders & leadership

TS
Timothy SullivanDirector
PK
Peter KolchinskyDirector
MA
Mark A. VellecaExecutive Officer, Director
GM
Glenn MuirDirector
GM
Gregory MossinghoffExecutive Officer
SR
Seth RudnickDirector
RL
Ron LauferDirector
FN
Frederic N. EshelmanDirector
CS
Christy ShafferDirector

Investors · 5

Lumira VenturesToronto · $1M – $10M
Mountain Group CapitalNashville
RA CapitalBostonvia Peter Kolchinsky · board
Solasta VenturesBoston
Hatteras Venture Partnersreported · 2 sourcesResearch Triangle · $500K – $4Mvia Clay Thorp · board

Reported raises · per SEC filings

Form D private placements
▶$50MraisedJul 2016 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy SullivanDirector
  • Peter KolchinskyDirector
  • Mark A. VellecaExecutive Officer, Director
  • Glenn MuirDirector
  • Gregory MossinghoffExecutive Officer
  • Seth RudnickDirector
  • Ron LauferDirector
  • Frederic N. EshelmanDirector
  • Christy ShafferDirector
Offering amount
$50M
Amount sold
$50M
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.5MraisedFeb 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron LauferDirector
  • Christy ShafferDirector
  • Seth RudnickDirector
  • Carol WebbDirector
  • Clay ThorpDirector
  • Michael GutchDirector
  • Mark A. VellecaExecutive Officer, Director
  • Norman SharplessDirector
  • Gregory MossinghoffExecutive Officer
Offering amount
$33M
Amount sold
$16.5M
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.